In the past week, VIRI stock has gone up by 11.38%, with a monthly decline of -9.19% and a quarterly surge of 17.60%. The volatility ratio for the week is 14.03%, and the volatility levels for the last 30 days are 10.63% for Virios Therapeutics Inc. The simple moving average for the past 20 days is 7.98% for VIRI’s stock, with a -48.99% simple moving average for the past 200 days.
Is It Worth Investing in Virios Therapeutics Inc (NASDAQ: VIRI) Right Now?
The stock has a 36-month beta value of 1.61. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for VIRI is 24.06M, and at present, short sellers hold a 2.41% of that float. On August 26, 2024, the average trading volume of VIRI was 1.57M shares.
VIRI) stock’s latest price update
Virios Therapeutics Inc (NASDAQ: VIRI)’s stock price has gone rise by 0.43 in comparison to its previous close of 0.21, however, the company has experienced a 11.38% increase in its stock price over the last five trading days. globenewswire.com reported 2024-08-08 that – Bateman Horne Center completed enrollment in its groundbreaking investigator-initiated Long-COVID phase 2a study featuring valacyclovir and celecoxib (IMC-2) –
VIRI Trading at -6.47% from the 50-Day Moving Average
After a stumble in the market that brought VIRI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.05% of loss for the given period.
Volatility was left at 10.63%, however, over the last 30 days, the volatility rate increased by 14.03%, as shares sank -4.32% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -8.08% lower at present.
During the last 5 trading sessions, VIRI rose by +11.38%, which changed the moving average for the period of 200-days by -72.48% in comparison to the 20-day moving average, which settled at $0.1945. In addition, Virios Therapeutics Inc saw -63.39% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for VIRI
The total capital return value is set at -1.53. Equity return is now at value -119.56, with -105.77 for asset returns.
Currently, EBITDA for the company is -5.45 million with net debt to EBITDA at 0.63. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.27.
Conclusion
To sum up, Virios Therapeutics Inc (VIRI) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
